MindImmune Therapeutics: Funding, Investors & Team (Oct 2026)
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
MindImmune Therapeutics has raised $15.2M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Mar 2026.
That round is below the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
MindImmune Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
MindImmune Therapeutics Funding Rounds
MindImmune Therapeutics raised $10.2M in a Series A announced in Nov 2025.
4 months later, an undisclosed round of $5.0M was announced in Mar 2026.
MindImmune Therapeutics Founders and Leadership Team
Contact details for the MindImmune Therapeutics team: 1 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →MindImmune Therapeutics Funding in Context
MindImmune Therapeutics' latest round of $5.0M is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MindImmune Therapeutics in Pharmaceuticals and Kingston
Companies Similar to MindImmune Therapeutics
Avanzanite Bioscience enhances access to orphan drugs in Europe, partnering with pharma for rare disease…
Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
MindImmune Therapeutics Funding FAQs
What does MindImmune Therapeutics do?
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
How much funding has MindImmune Therapeutics raised?
MindImmune Therapeutics has raised $15.2M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Mar 2026.
When did MindImmune Therapeutics last raise funding?
MindImmune Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Mar 2026.
Who founded MindImmune Therapeutics?
FundedIQ lists Frank S Menniti (Founder), Stevin Zorn (Founder) at MindImmune Therapeutics.
Where is MindImmune Therapeutics headquartered?
MindImmune Therapeutics is based in Kingston, United States.
How many employees does MindImmune Therapeutics have?
MindImmune Therapeutics is in the 1-10 employee band.
About FundedIQ's MindImmune Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MindImmune Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.